HEYA8 Cells

The HEYA8 cell line is a well-characterized model of human ovarian cancer, originally established from a patient with papillary cystadenocarcinoma. This cell line is particularly notable for its aggressive growth and metastatic potential, commonly used in research involving ovarian cancer pathophysiology and therapeutic studies. HEYA8 cells have been extensively studied for their expression of interleukin-8 (IL-8), a chemokine linked to cancer progression. IL-8 acts as an autocrine growth factor, enhancing proliferation, angiogenesis, and tumor invasiveness. Notably, high levels of IL-8 expression correlate with increased tumor growth and microvessel density in HEYA8 cells. Experimental transfections with IL-8 vectors have demonstrated that augmented IL-8 expression can significantly boost tumor proliferation, while neutralizing antibodies reduce this growth.

HEYA8 cells have also been utilized to study the response of ovarian cancer to various stress conditions, such as hypoxia. Hypoxia triggers IL-8 overexpression in these cells, mediated by pathways involving PI3K/Akt and p38 MAPK. The activation of these pathways enhances IL-8 gene transcription through factors like AP-1 and NF-κB, contributing to the tumor’s adaptation to low oxygen environments and supporting its survival and metastatic potential. Consequently, inhibitors targeting the PI3K and p38 MAPK pathways are being explored as potential strategies to mitigate the aggressive characteristics of HEYA8 cells and reduce tumor progression.